Stellar Lyman-alpha Emission Lines in the Hubble Space Telescope Archive: Intrinsic Line Fluxes and Absorption from the Heliosphere and Astrospheres

We search the Hubble Space Telescope (HST) archive for previously unanalyzed observations of stellar H I Lyman-alpha emission lines, our primary purpose being to look for new detections of Lyman-alpha absorption from the outer heliosphere, and to also search for analogous absorption from the astrospheres surrounding the observed stars. The astrospheric absorption is of particular interest because it can be used to study solar-like stellar winds that are otherwise undetectable. We find and analyze 33 HST Lyman-alpha spectra in the archive. All the spectra were taken with the E140M grating of the Space Telescope Imaging Spectrograph (STIS) instrument on board HST. The HST/STIS spectra yield 4 new detections of heliospheric absorption (70 Oph, Xi Boo, 61 Vir, and HD 165185) and 7 new detections of astrospheric absorption (EV Lac, 70 Oph, Xi Boo, 61 Vir, Delta Eri, HD 128987, and DK UMa), doubling the previous number of heliospheric and astrospheric detections. When combined with previous results, 10 of 17 lines of sight within 10 pc yield detections of astrospheric absorption. This high detection fraction implies that most of the ISM within 10 pc must be at least partially neutral, since the presence of H I within the ISM surrounding the observed star is necessary for an astrospheric detection. In contrast, the detection percentage is only 9.7% (3 out of 31) for stars beyond 10 pc. Our Lyman-alpha analyses provide measurements of ISM H I and D I column densities for all 33 lines of sight, and we discuss some implications of these results. Finally, we measure chromospheric Lyman-alpha fluxes from the observed stars. We use these fluxes to determine how Lyman-alpha flux correlates with coronal X-ray and chromospheric Mg II emission, and we also study how Lyman-alpha emission depends on stellar rotation.Comment: 56 pages, 15 figures; AASTEX v5.0 plus EPSF extensions in mkfig.sty; accepted by ApJ

Networking research in front ending and intelligent terminals : H6000 software specifications

"CCTC-WAD document no. 7501.""Prepared for the Command and Control Technical Center, WWMCCS ADP Directorate, Defense Communications Agency, Washington, D. C."Bibliography: leaf 26

The Physics of the B Factories

This work is on the Physics of the B Factories. Part A of this book contains a brief description of the SLAC and KEK B Factories as well as their detectors, BaBar and Belle, and data taking related issues. Part B discusses tools and methods used by the experiments in order to obtain results. The results themselves can be found in Part C

Identification and structural characterization of FYVE domain-containing proteins of Arabidopsis thaliana

<p>Abstract</p> <p>Background</p> <p>FYVE domains have emerged as membrane-targeting domains highly specific for phosphatidylinositol 3-phosphate (PtdIns(3)<it>P</it>). They are predominantly found in proteins involved in various trafficking pathways. Although FYVE domains may function as individual modules, dimers or in partnership with other proteins, structurally, all FYVE domains share a fold comprising two small characteristic double-stranded β-sheets, and a C-terminal α-helix, which houses eight conserved Zn²⁺ion-binding cysteines. To date, the structural, biochemical, and biophysical mechanisms for subcellular targeting of FYVE domains for proteins from various model organisms have been worked out but plant FYVE domains remain noticeably under-investigated.</p> <p>Results</p> <p>We carried out an extensive examination of all <it>Arabidopsis </it>FYVE domains, including their identification, classification, molecular modeling and biophysical characterization using computational approaches. Our classification of fifteen <it>Arabidopsis </it>FYVE proteins at the outset reveals unique domain architectures for FYVE containing proteins, which are not paralleled in other organisms. Detailed sequence analysis and biophysical characterization of the structural models are used to predict membrane interaction mechanisms previously described for other FYVE domains and their subtle variations as well as novel mechanisms that seem to be specific to plants.</p> <p>Conclusions</p> <p>Our study contributes to the understanding of the molecular basis of FYVE-based membrane targeting in plants on a genomic scale. The results show that FYVE domain containing proteins in plants have evolved to incorporate significant differences from those in other organisms implying that they play a unique role in plant signaling pathways and/or play similar/parallel roles in signaling to other organisms but use different protein players/signaling mechanisms.</p

Economic Analysis of Knowledge: The History of Thought and the Central Themes

Following the development of knowledge economies, there has been a rapid expansion of economic analysis of knowledge, both in the context of technological knowledge in particular and the decision theory in general. This paper surveys this literature by identifying the main themes and contributions and outlines the future prospects of the discipline. The wide scope of knowledge related questions in terms of applicability and alternative approaches has led to the fragmentation of research. Nevertheless, one can identify a continuing tradition which analyses various aspects of the generation, dissemination and use of knowledge in the economy

The genetic architecture of the human cerebral cortex

The cerebral cortex underlies our complex cognitive capabilities, yet little is known about the specific genetic loci that influence human cortical structure. To identify genetic variants that affect cortical structure, we conducted a genome-wide association meta-analysis of brain magnetic resonance imaging data from 51,665 individuals. We analyzed the surface area and average thickness of the whole cortex and 34 regions with known functional specializations. We identified 199 significant loci and found significant enrichment for loci influencing total surface area within regulatory elements that are active during prenatal cortical development, supporting the radial unit hypothesis. Loci that affect regional surface area cluster near genes in Wnt signaling pathways, which influence progenitor expansion and areal identity. Variation in cortical structure is genetically correlated with cognitive function, Parkinson's disease, insomnia, depression, neuroticism, and attention deficit hyperactivity disorder

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049